Post by Palo Alto Veterans Institute for Research

Congratulations to Dr. Fearon and the ALL_RISE study team on their recent publication in the New England Journal of Medicine: “Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment: The ALL-RISE Randomized Trial.”   This important work highlights how innovative approaches like FFRangio can streamline care while maintaining strong clinical outcomes, an exciting advancement for patients and providers alike.   VAPAHCS is proud to have been a top enroller in this trial and honored to play a role in advancing the future of cardiovascular care. 👏 https://lnkd.in/gqZRNF8m